{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:51:12Z","timestamp":1781664672222,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA161056"],"award-info":[{"award-number":["R01CA161056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eisai Inc.","award":["Research Support Agreement"],"award-info":[{"award-number":["Research Support Agreement"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12640-018-9929-8","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T03:51:16Z","timestamp":1532577076000},"page":"677-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Differential Morphological and Biochemical Recovery from Chemotherapy-Induced Peripheral Neuropathy Following Paclitaxel, Ixabepilone, or Eribulin Treatment in Mouse Sciatic Nerves"],"prefix":"10.1007","volume":"34","author":[{"given":"B. M.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. S.","family":"Slusher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Littlefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-6759","authenticated-orcid":false,"given":"Stuart C.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"issue":"4","key":"9929_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrm2369","volume":"9","author":"A Akhmanova","year":"2008","unstructured":"Akhmanova A, Steinmetz MO (2008) Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol 9(4):309\u2013322","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"9929_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2008.01.008","volume":"66","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Koltzenburg M, Polychronopoulos P, Papapetropoulos S, Kalofonos HP (2008) Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol 66(3):218\u2013228","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"9929_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","volume":"82","author":"AA Argyriou","year":"2012","unstructured":"Argyriou AA, Bruna J, Marmiroli P, Cavaletti G (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82(1):51\u201377","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"9929_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12640-015-9580-6","volume":"29","author":"SJ Benbow","year":"2016","unstructured":"Benbow SJ, Cook BM, Reifert J, Wozniak KM, Slusher BS, Littlefield BA, Wilson L, Jordan MA, Feinstein SC (2016) Effects of paclitaxel and eribulin in mouse sciatic nerve: a microtubule-based rationale for the differential induction of chemotherapy-induced peripheral neuropathy. Neurotox Res 29(2):299\u2013313","journal-title":"Neurotox Res"},{"key":"9929_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/2193-1801-3-366","volume":"3","author":"B Bhatnagar","year":"2014","unstructured":"Bhatnagar B, Gilmore S, Goloubeva O, Pelser C, Medeiros M, Chumsri S, Tkaczuk K, Edelman M, Bao T (2014) Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springer Plus 3:366","journal-title":"Springer Plus"},{"issue":"11","key":"9929_CR6","first-page":"2325","volume":"55","author":"DM Bollag","year":"1995","unstructured":"Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55(11):2325\u20132333","journal-title":"Cancer Res"},{"issue":"3","key":"9929_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00280-012-2047-z","volume":"71","author":"JA Boyette-Davis","year":"2013","unstructured":"Boyette-Davis JA, Cata JP, Driver LC, Novy DM, Bruel BM, Mooring DL, Wendelschafer-Crabb G, Kennedy WR, Dougherty PM (2013) Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemother Pharmacol 71(3):619\u2013626","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"9929_CR8","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1016\/j.cub.2006.11.036","volume":"17","author":"JC Bulinski","year":"2007","unstructured":"Bulinski JC (2007) Microtubule Modification: Acetylation Speeds Anterograde Traffic Flow. Curr Biol 17(1):R18\u2013R20","journal-title":"Curr Biol"},{"key":"9929_CR9","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1091\/mbc.e04-01-0062","volume":"15","author":"JM Bunker","year":"2004","unstructured":"Bunker JM, Wilson L, Jordan MA, Feinstein SC (2004) Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration. Mol Biol Cell 15:2720\u20132728","journal-title":"Mol Biol Cell"},{"issue":"2","key":"9929_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/jns5.12073","volume":"19","author":"G Cavaletti","year":"2014","unstructured":"Cavaletti G (2014) Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know. J Peripher Nerv Syst 19(2):66\u201376","journal-title":"J Peripher Nerv Syst"},{"issue":"12","key":"9929_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","volume":"6","author":"G Cavaletti","year":"2010","unstructured":"Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6(12):657\u2013666","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"9929_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","volume":"46","author":"G Cavaletti","year":"2010","unstructured":"Cavaletti G, Frigeni B, Lanzani F, Mattavelli L, Susani E, Alberti P, Cortinovis D, Bidoli P (2010) Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 46(3):479\u2013494","journal-title":"Eur J Cancer"},{"issue":"1","key":"9929_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1749-8104-9-22","volume":"9","author":"M Ceci","year":"2014","unstructured":"Ceci M, Mardones-Krsulovic C, S\u00e1nchez M, Valdivia LE, Allende ML (2014) Axon-Schwann cell interactions during peripheral nerve regeneration in zebrafish larvae. Neural Dev 9(1):22","journal-title":"Neural Dev"},{"issue":"18","key":"9929_CR14","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1101\/gad.1685008","volume":"22","author":"Y-J Choi","year":"2008","unstructured":"Choi Y-J, Di Nardo A, Kramvis I, Meikle L, Kwiatkowski DJ, Sahin M, He X (2008) Tuberous sclerosis complex proteins control axon formation. Genes Dev 22(18):2485\u20132495","journal-title":"Genes Dev"},{"issue":"12","key":"9929_CR15","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1200\/JCO.1994.12.12.2682","volume":"12","author":"H Choy","year":"1994","unstructured":"Choy H, Akerley W, Safran H, Clark J, Rege V, Papa A, Glantz M, Puthawala Y, Soderberg C, Leone L (1994) Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol 12(12):2682\u20132686","journal-title":"J Clin Oncol"},{"issue":"9769","key":"9929_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(11)60070-6","volume":"377","author":"J Cortes","year":"2011","unstructured":"Cortes J, O\u2019Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Di\u00e9ras V, Delozier T, Vladimirov V, Cardoso F, Koh H, Bougnoux P, Dutcus CE, Seegobin S, Mir D, Meneses N, Wanders J, Twelves C, EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician\u2019s Choice Versus E7389) investigators (2011) Eribulin monotherapy versus treatment of physician\u2019s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Lancet 377(9769):914\u2013923","journal-title":"Lancet"},{"issue":"2","key":"9929_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ctrv.2011.03.006","volume":"38","author":"J Cortes","year":"2012","unstructured":"Cortes J, Montero AJ, Gl\u00fcck S (2012) Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer. Cancer Treat Rev 38(2):143\u2013151","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"9929_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2008.11.043","volume":"136","author":"C Creppe","year":"2009","unstructured":"Creppe C, Malinouskaya L, Volvert M-L, Gillard M, Close P, Malaise O, Laguesse S, Cornez I, Rahmouni S, Ormenese S, Belachew S, Malgrange B, Chapelle J-P, Siebenlist U, Moonen G, Chariot A, Nguyen L (2009) Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of \u00ce\u00b1-Tubulin. Cell 136(3):551\u2013564","journal-title":"Cell"},{"issue":"4","key":"9929_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.6004\/jnccn.2015.0057","volume":"13","author":"P de la Morena Barrio","year":"2015","unstructured":"de la Morena Barrio P, Conesa M\u00c1, Gonz\u00e1lez-Billalabeitia E, Urrego E, Garc\u00eda-Garre E, Garc\u00eda-Mart\u00ednez E, Poves MZ, Vicente V, de la Pe\u00f1a FA (2015) Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Cancer Netw 13(4):417\u2013423","journal-title":"J Natl Compr Cancer Netw"},{"issue":"7","key":"9929_CR20","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1021\/bi00007a014","volume":"34","author":"WB Derry","year":"1995","unstructured":"Derry WB, Wilson L, Jordan MA (1995) Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34(7):2203\u20132211","journal-title":"Biochemistry"},{"issue":"4","key":"9929_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/cncr.22839","volume":"110","author":"R Dreicer","year":"2007","unstructured":"Dreicer R, Li S, Manola J, Haas NB, Roth BJ, Wilding G, Eastern Cooperative Oncology Group (2007) Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology Group. Cancer 110(4):759\u2013763","journal-title":"Cancer"},{"issue":"1-2","key":"9929_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","volume":"109","author":"PM Dougherty","year":"2004","unstructured":"Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109(1-2):132\u2013142","journal-title":"Pain"},{"issue":"10","key":"9929_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3253","volume":"9","author":"C Dumontet","year":"2010","unstructured":"Dumontet C, Jordan MA (2010) Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 9(10):790\u2013803","journal-title":"Nat Rev Drug Discov"},{"key":"9929_CR24","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1016\/j.bmc.2014.02.035","volume":"22","author":"JJ Field","year":"2014","unstructured":"Field JJ, Kanakkanthara A, Miller JH (2014) Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. Bioorg Med Chem 22:5050\u20135059","journal-title":"Bioorg Med Chem"},{"issue":"2\u20133","key":"9929_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbadis.2004.07.002","volume":"1739","author":"SC Feinstein","year":"2005","unstructured":"Feinstein SC, Wilson L (2005) Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim Biophys Acta 1739(2\u20133):268\u2013279","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9929_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrm3494","volume":"14","author":"EA Foley","year":"2013","unstructured":"Foley EA, Kapoor TM (2013) Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat Rev Mol Cell Biol 14(1):25\u201337","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"9929_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1005805907311","volume":"35","author":"PA Forsyth","year":"1997","unstructured":"Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM (1997) Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neuro-Oncol 35(1):47\u201353","journal-title":"J Neuro-Oncol"},{"issue":"1\u20132","key":"9929_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF02740621","volume":"14","author":"S Fu","year":"1997","unstructured":"Fu S, Gordon T (1997) The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14(1\u20132):67\u2013116","journal-title":"Mol Neurobiol"},{"issue":"10","key":"9929_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/ncb1778","volume":"10","author":"S Geraldo","year":"2008","unstructured":"Geraldo S, Khanzada UK, Parsons M, Chilton JK, Gordon-Weeks PR (2008) Targeting of the F-actin-binding protein drebrin by the microtubule plus-tip protein EB3 is required for neuritogenesis. Nat Cell Biol 10(10):1181\u20131189","journal-title":"Nat Cell Biol"},{"issue":"6","key":"9929_CR30","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1073\/pnas.040546297","volume":"97","author":"P Giannakakou","year":"2000","unstructured":"Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC, Fojo T (2000) A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci 97(6):2904\u20132909","journal-title":"Proc Natl Acad Sci"},{"key":"9929_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","volume":"76","author":"E Gornstein","year":"2014","unstructured":"Gornstein E, Schwarz TL (2014) The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions. Neuropharmacology 76:175\u2013183","journal-title":"Neuropharmacology"},{"issue":"Suppl 4","key":"9929_CR32","doi-asserted-by":"publisher","first-page":"iv45","DOI":"10.1093\/neuonc\/nos203","volume":"14","author":"W Grisold","year":"2012","unstructured":"Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14(Suppl 4):iv45\u2013iv54","journal-title":"Neuro Oncol"},{"issue":"5","key":"9929_CR33","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuron.2006.10.022","volume":"52","author":"Chen Gu","year":"2006","unstructured":"Gu Chen, Zhou W, Puthenveedu MA, Xu M, Jan YN, Jan LY (2006) The Microtubule Plus-End Tracking Protein EB1 Is Required for Kv1 Voltage-Gated K+ Channel Axonal Targeting. Neuron 52(5):803\u2013816","journal-title":"Neuron"},{"issue":"7","key":"9929_CR34","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1083\/jcb.201307057","volume":"204","author":"BA Heller","year":"2014","unstructured":"Heller BA, Ghidinelli M, Voelkl J, Einheber S, Smith R, Grund E, Morahan G, Chandler D, Kalaydjieva L, Giancotti F, King RH, Fejes-Toth AN, Fejes-Toth G, Feltri ML, Lang F, Salzer JL (2014) Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. J Cell Biol 204(7):1219\u20131236","journal-title":"J Cell Biol"},{"issue":"3","key":"9929_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, Awad D, Crew KD (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767\u2013774","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 6","key":"9929_CR36","first-page":"S3","volume":"5","author":"SB Horwitz","year":"1994","unstructured":"Horwitz SB (1994) Taxol (paclitaxel): mechanisms of action. Ann Oncol 5(Suppl 6):S3\u2013S6","journal-title":"Ann Oncol"},{"issue":"21","key":"9929_CR37","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1158\/1078-0432.CCR-11-1807","volume":"17","author":"S Jain","year":"2011","unstructured":"Jain S, Vahdat LT (2011) Eribulin mesylate. Clin Cancer Res 17(21):6615\u20136622","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9929_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuron.2008.11.013","volume":"61","author":"J Jaworski","year":"2009","unstructured":"Jaworski J, Kapitein LC, Gouveia SM, Dortland BR, Wulf PS, Grigoriev I, Camera P, Spangler SA, Di Stefano P, Demmers J, Krugers H, Defilippi P, Akhmanova A, Hoogenraad CC (2009) Dynamic Microtubules Regulate Dendritic Spine Morphology and Synaptic Plasticity. Neuron 61(1):85\u2013100","journal-title":"Neuron"},{"issue":"1","key":"9929_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ceb.2010.08.008","volume":"23","author":"K Jiang","year":"2011","unstructured":"Jiang K, Akhmanova A (2011) Microtubule tip-interacting proteins: a view from both ends. Curr Opin Cell Biol 23(1):94\u2013101","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"9929_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jnr.20453","volume":"80","author":"EM Jim\u00e9nez-Mateos","year":"2005","unstructured":"Jim\u00e9nez-Mateos EM, Paglini G, Gonz\u00e1lez-Billault C, C\u00e1ceres A, Avila J (2005) End binding protein-1 (EB1) complements microtubule-associated protein-1B during axonogenesis. J Neurosci Res 80(3):350\u2013359","journal-title":"J Neurosci Res"},{"issue":"4","key":"9929_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4(4):253\u2013265","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"9929_CR42","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","volume":"90","author":"MA Jordan","year":"1993","unstructured":"Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci 90(20):9552\u20139556","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"9929_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/JCO.2013.52.4892","volume":"33","author":"PA Kaufman","year":"2015","unstructured":"Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J (2015) Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane. J Clin Oncol 33(6):594\u2013601","journal-title":"J Clin Oncol"},{"issue":"6","key":"9929_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2174\/187152710793237412","volume":"9","author":"HC Lehmann","year":"2010","unstructured":"Lehmann HC, H\u00f6ke A (2010) Schwann cells as a therapeutic target for peripheral neuropathies. CNS Neurol Disord Drug Targets 9(6):801\u2013806 Review","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"9929_CR45","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","volume":"40","author":"NC Miltenburg","year":"2014","unstructured":"Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev 40(7):872\u2013882","journal-title":"Cancer Treat Rev"},{"issue":"32","key":"9929_CR46","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1523\/JNEUROSCI.0935-13.2013","volume":"33","author":"AJ Moughamian","year":"2013","unstructured":"Moughamian AJ, Osborn GE, Lazarus JE, Maday S, Holzbaur ELF (2013) Ordered Recruitment of Dynactin to the Microtubule Plus-End is Required for Efficient Initiation of Retrograde Axonal Transport. J Neurosci 33(32):13190\u201313203","journal-title":"J Neurosci"},{"key":"9929_CR47","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/00000542-200606000-00021","volume":"104","author":"T Muguruma","year":"2006","unstructured":"Muguruma T, Sakura S, Kirihara Y, Saito Y (2006) Comparativesomatic and visceral antinociception and neurotoxicity of intrathecal bupivacaine, levobupivacaine, and dextrobupivacaine in rats. Anesthesiology 104:1249\u20131256","journal-title":"Anesthesiology"},{"issue":"6530","key":"9929_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/375424a0","volume":"375","author":"E Nogales","year":"1995","unstructured":"Nogales E, Wolf SG, Khan IA, Luduena RF, Downing KH (1995) Structure of tubulin at 6.5 A and location of the taxol-binding site. Nature 375(6530):424\u2013427","journal-title":"Nature"},{"issue":"8","key":"9929_CR49","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1073\/pnas.96.8.4256","volume":"96","author":"I Ojima","year":"1999","unstructured":"Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SD, Danishefsky SJ (1999) A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci 96(8):4256\u20134261","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"9929_CR50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3816\/CBC.2007.n.010","volume":"7","author":"A Pace","year":"2007","unstructured":"Pace A, Nistic\u00f2 C, Cuppone F, Bria E, Gali\u00e8 E, Graziano G, Natoli G, Sperduti I, Jandolo B, Calabretta F, Tomao S, Terzoli E (2007) Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue? Clin Breast Cancer 7(7):550\u2013554","journal-title":"Clin Breast Cancer"},{"issue":"23","key":"9929_CR51","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1200\/JCO.2006.09.3849","volume":"25","author":"EA Perez","year":"2007","unstructured":"Perez EA, Lerzo G, Pivot X, Thomas E, Vahdat L, Bosserman L, Viens P, Cai C, Mullaney B, Peck R, Hortobagyi GN (2007) Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine. J Clin Oncol 25(23):3407\u20133414","journal-title":"J Clin Oncol"},{"issue":"5","key":"9929_CR52","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1073\/pnas.1416418112","volume":"112","author":"MS Poruchynsky","year":"2015","unstructured":"Poruchynsky MS, Komlodi-Pasztor E, Trostel S, Wilkerson J, Regairaz M, Pommier Y, Xu Z, Maity TK, Robey R, Burotto M, Sackett D, Guha U, Fojo AT (2015) Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins. Proc Natl Acad Sci 112(5):1571\u20131576","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"9929_CR53","first-page":"505","volume":"2","author":"S Puhalla","year":"2008","unstructured":"Puhalla S, Brufsky A (2008) Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer. Biologics 2(3):505\u2013515","journal-title":"Biologics"},{"key":"9929_CR54","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.cub.2006.09.014","volume":"16","author":"NA Reed","year":"2006","unstructured":"Reed NA, Cai D, Blasius TL, Jih GT, Meyhofer E, Gaertig J, Verhey KJ (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16:2166\u20132172","journal-title":"Curr Biol"},{"issue":"23","key":"9929_CR55","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1200\/JCO.2006.09.7535","volume":"25","author":"H Roch\u00e9","year":"2007","unstructured":"Roch\u00e9 H, Yelle L, Cognetti F, Mauriac L, Bunnell C, Sparano J, Kerbrat P, Delord JP, Vahdat L, Peck R, Lebwohl D, Ezzeddine R, Cur\u00e9 H (2007) Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy. J Clin Oncol 25(23):3415\u20133420","journal-title":"J Clin Oncol"},{"issue":"6","key":"9929_CR56","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bcp.2010.04.018","volume":"80","author":"A Rovini","year":"2010","unstructured":"Rovini A, Carr\u00e9 M, Bordet T, Pruss RM, Braguer D (2010) Olesoxime prevents microtubule-targeting drug neurotoxicity: Selective preservation of EB comets in differentiated neuronal cells. Biochem Pharmacol 80(6):884\u2013894","journal-title":"Biochem Pharmacol"},{"issue":"4 Suppl 3","key":"9929_CR57","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered by paclitaxel (Taxol). Semin Oncol 20(4 Suppl 3):1\u201315","journal-title":"Semin Oncol"},{"key":"9929_CR58","doi-asserted-by":"crossref","unstructured":"Scherer S, Salzer J. (1997) Axon\u2013Schwann cell interactions during peripheral nerve degeneration and regeneration. In Glial Cell Development: basic principles and clinical relevance. Oxford University Press. Retrieved 30 Jun. 2018, from \n                    http:\/\/www.oxfordscholarship.com\/view\/10.1093\/acprof:oso\/9781872748542.001.0001\/acprof-9781872748542-chapter-9","DOI":"10.1093\/acprof:oso\/9781872748542.003.0009"},{"issue":"1","key":"9929_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ar.1092150111","volume":"215","author":"H Schmalbruch","year":"1986","unstructured":"Schmalbruch H (1986) Fiber composition of the rat sciatic nerve. Anat Rec 215(1):71\u201381","journal-title":"Anat Rec"},{"issue":"12","key":"9929_CR60","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00520-009-0613-7","volume":"17","author":"K Shimozuma","year":"2009","unstructured":"Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H, Katsumata N, Sunada Y, Watanabe T, Hausheer FH (2009) Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer 17(12):1483\u20131491","journal-title":"Support Care Cancer"},{"issue":"6","key":"9929_CR61","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1021\/bi901810u","volume":"49","author":"JA Smith","year":"2010","unstructured":"Smith JA, Wilson L, Azarenko O, Zhu X, Lewis BM, Littlefield BA, Jordan MA (2010) Eribulin Binds at Microtubule Ends to a Single Site on Tubulin To Suppress Dynamic Instability. Biochemistry 49(6):1331\u20131337","journal-title":"Biochemistry"},{"key":"9929_CR62","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.clinthera.2008.09.015","volume":"30","author":"M Steinberg","year":"2008","unstructured":"Steinberg M (2008) Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer. Clin Ther 30:1590\u20131617","journal-title":"Clin Ther"},{"issue":"2","key":"9929_CR63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2011.03.002","volume":"81","author":"U Swami","year":"2012","unstructured":"Swami U, Chaudhary I, Ghalib MH, Goel S (2012) Eribulin\u2014a review of preclinical and clinical studies. Crit Rev Oncol Hematol 81(2):163\u2013184","journal-title":"Crit Rev Oncol Hematol"},{"issue":"23","key":"9929_CR64","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1200\/JCO.2006.08.9102","volume":"25","author":"E Thomas","year":"2007","unstructured":"Thomas E, Tabernero J, Fornier M, Cont\u00e9 P, Fumoleau P, Lluch A, Vahdat LT, Bunnell CA, Burris HA, Viens P, Baselga J, Rivera E, Guarneri V, Poulart V, Klimovsky J, Lebwohl D, Martin M (2007) Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer. J Clin Oncol 25(23):3399\u20133406","journal-title":"J Clin Oncol"},{"issue":"18","key":"9929_CR65","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1200\/JCO.2008.17.7618","volume":"27","author":"LT Vahdat","year":"2009","unstructured":"Vahdat LT, Pruitt B, Fabian CJ, Rivera RR, Smith DA, Tan-Chiu E, Wright J, Tan AR, Dacosta NA, Chuang E, Smith J, O\u2019Shaughnessy J, Shuster DE, Meneses NL, Chandrawansa K, Fang F, Cole PE, Ashworth S, Blum JL (2009) Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol 27(18):2954\u20132961","journal-title":"J Clin Oncol"},{"issue":"2","key":"9929_CR66","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10549-013-2574-2","volume":"140","author":"LT Vahdat","year":"2013","unstructured":"Vahdat LT, Garcia AA, Vogel C, Pellegrino C, Lindquist DL, Iannotti N, Gopalakrishna P, Sparano JA (2013) Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized phase II study comparing the incidence of peripheral neuropathy. Breast Cancer Res Treat 140(2):341\u2013351","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"9929_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ncb1703","volume":"10","author":"B Vitre","year":"2008","unstructured":"Vitre B, Coquelle FM, Heichette C, Garnier C, Chr\u00e9tien D, Arnal I (2008) EB1 regulates microtubule dynamics and tubulin sheet closure in vitro. Nat Cell Biol 10(4):415\u2013421","journal-title":"Nat Cell Biol"},{"issue":"5","key":"9929_CR68","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1083\/jcb.141.5.1181","volume":"141","author":"JC Waters","year":"1998","unstructured":"Waters JC, Chen R-H, Murray AW, Salmon ED (1998) Localization of Mad2 to Kinetochores Depends on Microtubule Attachment, Not Tension. J Cell Biol 141(5):1181\u20131191","journal-title":"J Cell Biol"},{"issue":"11","key":"9929_CR69","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1158\/0008-5472.CAN-10-4184","volume":"71","author":"KM Wozniak","year":"2011","unstructured":"Wozniak KM, Nomoto K, Lapidus RG, Wu Y, Carozzi V, Cavaletti G, Hayakawa K, Hosokawa S, Towle MJ, Littlefield BA, Slusher BS (2011) Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. Cancer Res 71(11):3952\u20133962","journal-title":"Cancer Res"},{"issue":"3","key":"9929_CR70","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12640-013-9394-3","volume":"24","author":"KM Wozniak","year":"2013","unstructured":"Wozniak KM, Ying W, Farah MH, Littlefield BA, Nomoto K, Slusher BS (2013) Neuropathy-inducing effects of eribulin mesylate versus paclitaxel in mice with preexisting neuropathy. Neurotox Res 24(3):338\u2013344","journal-title":"Neurotox Res"},{"issue":"11","key":"9929_CR71","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-15-2525","volume":"76","author":"KM Wozniak","year":"2016","unstructured":"Wozniak KM, Vornov JJ, Wu Y, Nomoto K, Littlefield BA, DesJardins C, Yu Y, Lai G, Reyderman L, Wong N, Slusher BS (2016) Sustained accumulation of microtubule-binding chemotherapy drugs in the peripheral nervous system: correlations with time course and neurotoxic severity. Cancer Res 76(11):3332\u20133339","journal-title":"Cancer Res"},{"issue":"11","key":"9929_CR72","doi-asserted-by":"publisher","first-page":"9514","DOI":"10.1074\/jbc.M110.134908","volume":"286","author":"T Zhang","year":"2011","unstructured":"Zhang T, Yao S, Wang P, Yin C, Xiao C, Qian M, Liu D, Zheng L, Meng W, Zhu H, Liu J, Xu H, Mo X (2011) ApoA-II Directs Morphogenetic Movements of Zebrafish Embryo by Preventing Chromosome Fusion during Nuclear Division in Yolk Syncytial Layer. J Biol Chem 286(11):9514\u20139525","journal-title":"J Biol Chem"},{"issue":"19","key":"9929_CR73","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1242\/jcs.046813","volume":"122","author":"Y Zilberman","year":"2009","unstructured":"Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A (2009) Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 122(19):3531\u20133541","journal-title":"J Cell Sci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-018-9929-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:21:54Z","timestamp":1589736114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-018-9929-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1007\/s12640-018-9929-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experimental protocols were approved by the Institutional Animal Care and Use Committee of John Hopkins University and adhered to all applicable institutional and governmental guidelines for humane treatment set forth in the Guide for the Care and Use of Laboratory Animals (Office of Laboratory Animal Welfare, NIH).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}